ArticleACS omega2025
A Multi-input Deep Learning Architecture for STAT3 Inhibitor Prediction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- STAT3 signaling inhibitors for cancer treatment.Trends in pharmacological sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Signal transducer and activator of transcription 3 (STAT3) is a critical factor involved in various physiological and oncogenic signaling pathways. Machine learning models are valuable tools for predicting or screening STAT3 inhibitors. However, the predictive performance and interpretability of existing models still require improvement. In this study, we introduce a fingerprint-enhanced graph (FPG) attention network model, which integrates sequence-based fingerprints and structure-based graph representations to predict STAT3 inhibitors. During the feature learning process, the FPG model converts sequence information into a fingerprint vector, while structural information is encoded into a separate vector using a graph attention network module. These two vectors are then concatenated and passed through a multilayer perceptron for molecular activity classification. Among 49 models with various representations and algorithm combinations, the FPG-based model achieved the best predictive performance, with an average area under the curve of 0.897 on the test set. Furthermore, the model outperformed existing prediction models for identifying STAT3 inhibitors. Additionally, fingerprint analysis and attention heatmaps, combined with SHAP algorithms, provided valuable insights into the structure-activity relationship of STAT3 inhibitors, enhancing model interpretability. To facilitate related research and applications, we developed a web service (STAT3 Pro: https://gzliang.cqu.edu.cn/software/Stat3Pro.html) for STAT3 inhibitor prediction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.